Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Other Accumulated Expenses (2024 - 2026)

Carlsmed filings provide 2 years of Other Accumulated Expenses readings, the most recent being $573000.0 for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 6.9% to $573000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $573000.0, a 6.9% increase, with the full-year FY2025 number at $573000.0, up 6.9% from a year prior.
  • Other Accumulated Expenses hit $573000.0 in Q4 2025 for Carlsmed, up from $325000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $573000.0 in Q4 2025 to a low of $325000.0 in Q3 2025.